BioCentury
ARTICLE | Distillery Therapeutics

Cancer

October 25, 2018 5:59 PM UTC

Mouse studies suggest nitric oxide precursors could help treat castration-resistant prostate cancer (CRPC). In a xenograft mouse model of CRPC, the endogenous NO precursor S-nitrosoglutathione decreas...

BCIQ Company Profiles

University of Miami

BCIQ Target Profiles

Nitric oxide (NO)